Aubay Société Anonyme (AUB) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue reached €136.2 million, down 3.0% year-over-year, reflecting negative calendar effects, especially in Italy.
Performance aligned with expectations; pricing trends remained positive, partially offsetting lower international headcount.
Group headcount stood at 7,425 at March 31, 2025, with a productivity rate of 92.4%.
Financial highlights
France revenue: €74.1 million, down 1.7% year-over-year; stable when adjusted for calendar effects.
International revenue: €62.1 million, down 4.4% year-over-year; stable on a comparable working day basis.
Total Q1 2025 revenue: €136.2 million, compared to €140.3 million in Q1 2024.
Outlook and guidance
Annual organic growth expected between 0% and 3%, targeting €540–556 million in revenue for 2025.
Recurring operating margin guidance set between 8.5% and 9.5%.
Favorable demand trends and positive pricing effects support confidence in full-year outlook.
Latest events from Aubay Société Anonyme
- Double-digit organic growth and raised 2026 guidance highlight strong business momentum.AUB
Q2 2026 TU - Q1 2026 revenue surged 30.9% year-over-year, driven by strong growth in France and robust demand.AUB
Q1 2026 TU - Record revenue and net income in 2025, with strong 2026 growth and margin guidance.AUB
H2 2025 - 2025 revenue rose 11.4% to €601.7M, with strong outlook and leadership changes ahead.AUB
Q4 2025 TU - Q3 2025 revenue jumped 23.9% year-over-year, prompting a raised full-year outlook.AUB
Q3 2025 TU - H1 2025 saw a 1.2% revenue drop and 16.9% lower net income, with annual targets and dividend maintained.AUB
H1 2025 - Q2 2025 saw modest growth, with France outperforming and Solutec set to drive future gains.AUB
H1 2025 TU - Stable earnings and robust cash flow support confirmed guidance amid a cautious market.AUB
H1 2024 - Q3 revenue up 4.3% organically; full-year targets and margin guidance reaffirmed.AUB
Q3 2024